{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T03:29:54Z","timestamp":1774236594850,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12020-021-02686-1","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T02:02:36Z","timestamp":1616464956000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Kidney malformations and Hirschsprung\u2019s disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6796-079X","authenticated-orcid":false,"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"key":"2686_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma, Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25, 567\u2013610 (2015)","journal-title":"Thyroid"},{"key":"2686_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. van Vroonhoven, H.D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, H. Dralle, European Multiple Endocrine Neoplasia (EUROMEN) Study Group, Early malignant progression of hereditary medullary thyroid cancer. N. Engl. J. Med. 349, 1517\u20131525 (2003)","journal-title":"N. Engl. J. Med."},{"key":"2686_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.23430","volume":"39","author":"A Machens","year":"2018","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Genotype-specific progression of hereditary medullary thyroid cancer. Hum. Mutat. 39, 860\u2013869 (2018)","journal-title":"Hum. Mutat."},{"key":"2686_CR4","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"I. Schuffenecker, M. Virally-Monod, R. Brohet, D. Goldgar, B. Conte-Devolx, L. Leclerc, O. Chabre, A. Boneu, J. Caron, C. Houdent, E. Modigliani, V. Rohmer, M. Schlumberger, C. Eng, P.J. Guillausseau, G.M. Lenoir, Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs \u00e0 Calcitonine. J. Clin. Endocrinol. Metab. 83, 487\u2013491 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2686_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/humu.21385","volume":"32","author":"K Frank-Raue","year":"2011","unstructured":"K. Frank-Raue, L.A. Rybicki, Z. Erlic, H. Schweizer, A. Winter, I. Milos, S.P. Toledo, R.A. Toledo, M.R. Tavares, M. Alevizaki, C. Mian, H. Siggelkow, M. H\u00fcfner, N. Wohllk, G. Opocher, S. Dvo\u0159\u00e1kov\u00e1, B. Bendlova, M. Czetwertynska, E. Skasko, M. Barontini, G. Sanso, C. Vorl\u00e4nder, A.L. Maia, A. Patocs, T.P. Links, J.W. de Groot, M.N. Kerstens, G.V. Valk, K. Miehle, T.J. Musholt, J. Biarnes, S. Damjanovic, M. Muresan, C. W\u00fcster, M. Fassnacht, M. Peczkowska, C. Fauth, H. Golcher, M.A. Walter, J. Pichl, F. Raue, C. Eng, H.P. Neumann, International RET Exon 10 Consortium, Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum. Mutat. 32, 51\u201358 (2011)","journal-title":"Hum. Mutat."},{"key":"2686_CR6","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"A. Machens, K. Lorenz, H. Dralle, Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J. Clin. Endocrinol. Metab. 98, E336\u2013E345 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2686_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"L. Mucha, G. Leidig-Bruckner, K. Frank-Raue, T. Bruckner, M. Kroiss, F. Raue, German study group for rare thyroid cancer, Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin. Endocrinol. 87, 320\u2013326 (2017)","journal-title":"Clin. Endocrinol."},{"key":"2686_CR8","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1093\/hmg\/3.12.2163","volume":"3","author":"LM Mulligan","year":"1994","unstructured":"L.M. Mulligan, C. Eng, T. Atti\u00e9, S. Lyonnet, D.J. Marsh, V.J. Hyland, B.G. Robinson, A. Frilling, C. Verellen-Dumoulin, A. Safar, D.J. Venter, A. Munnich, B.A.J. Ponder, Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum. Mol. Genet. 3, 2163\u20132167 (1994)","journal-title":"Hum. Mol. Genet."},{"key":"2686_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJM199609263351307","volume":"335","author":"C Eng","year":"1996","unstructured":"C. Eng, The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung\u2019s disease. N. Engl. J. Med. 335, 943\u2013951 (1996)","journal-title":"N. Engl. J. Med."},{"key":"2686_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0022-3468(98)90433-X","volume":"33","author":"RA Decker","year":"1998","unstructured":"R.A. Decker, M.L. Peacock, Occurrence of MEN 2a in familial Hirschsprung\u2019s disease: a new indication for genetic testing of the RET proto-oncogene. J. Pediatr. Surg. 33, 207\u2013214 (1998)","journal-title":"J. Pediatr. Surg."},{"key":"2686_CR11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJM200004203421615","volume":"342","author":"F Lor\u00e9","year":"2000","unstructured":"F. Lor\u00e9, G. Di Cairano, F. Talidis, Unilateral renal agenesis in a family with medullary thyroid carcinoma. N. Engl. J. Med. 342, 1218\u20131219 (2000)","journal-title":"N. Engl. J. Med."},{"key":"2686_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jpedsurg.2009.10.080","volume":"45","author":"SW Moore","year":"2010","unstructured":"S.W. Moore, M. Zaahl, Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 \u201cJanus\u201d genetic variation. J. Pediatr. Surg. 45, 393\u2013396 (2010)","journal-title":"J. Pediatr. Surg."},{"key":"2686_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/367380a0","volume":"367","author":"A Schuchardt","year":"1994","unstructured":"A. Schuchardt, V. D\u2019Agati, L. Larsson-Blomberg, F. Costantini, V. Pachnis, Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380\u2013383 (1994)","journal-title":"Nature"},{"key":"2686_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1210\/me.2003-0173","volume":"18","author":"E Arighi","year":"2004","unstructured":"E. Arighi, A. Popsueva, D. Degl\u2019Innocenti, M.G. Borrello, C. Carniti, N.M. Per\u00e4l\u00e4, M.A. Pierotti, H. Sariola, Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung\u2019s disease. Mol. Endocrinol. 18, 1004\u20131017 (2004)","journal-title":"Mol. Endocrinol."},{"key":"2686_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.2353\/ajpath.2006.050607","volume":"168","author":"C Carniti","year":"2006","unstructured":"C. Carniti, S. Belluco, E. Riccardi, A.N. Cranston, P. Mondellini, B.A. Ponder, E. Scanziani, M.A. Pierotti, I. Bongarzone, The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung\u2019s disease. Am. J. Pathol. 168, 1262\u20131275 (2006)","journal-title":"Am. J. Pathol."},{"key":"2686_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ijc.22378","volume":"121","author":"L Yin","year":"2007","unstructured":"L. Yin, A. Puliti, E. Bonora, C. Evangelisti, V. Conti, W.M. Tong, J.J. Medard, M.F. Lavou\u00e9, N. Forey, L.C. Wang, S. Mani\u00e9, G. Morel, M. Raccurt, Z.Q. Wang, G. Romeo, C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. Int. J. Cancer 121, 292\u2013300 (2007)","journal-title":"Int. J. Cancer"},{"key":"2686_CR17","first-page":"821","volume":"4","author":"M Angrist","year":"1995","unstructured":"M. Angrist, S. Bolk, B. Thiel, E.G. Puffenberger, R.M. Hofstra, C.H. Buys, D.T. Cass, A. Chakravarti, Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease, Hum. Mol. Genet. 4, 821\u2013830 (1995)","journal-title":"Mol. Genet."},{"key":"2686_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1677\/ERC-08-0096","volume":"16","author":"A Machens","year":"2009","unstructured":"A. Machens, S. Hauptmann, H. Dralle, Modification of multiple endocrine neoplasia 2A, phenotype by cell membrane proximity of RET mutations in exon 10. Endocr. Relat. Cancer 16, 171\u2013177 (2009)","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02686-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:26:53Z","timestamp":1623950813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2686"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02686-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"31 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from each patient and\/or legal guardian as applicable before each RET gene test and each operation, all of which represented standard of care.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}